Having trouble accessing articles? Reset your cache.

Allogeneic iMP cells: Phase II data

The Phase II HeartCel trial in advanced heart failure patients at high risk of incomplete revascularization

Read the full 164 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE